Trade Mark Journal No.2025/030 25 July 2025

UK00004228055 2 July 2025 (5,42)

Image for mark UK00004228055 RYCARMA THERAPEUTICS
International priority date claimed: 17 January 2025 (United States of America) (99008804)
Class 5
Pharmaceutical preparations for that restoring normal intracellular calcium regulation; Chemical preparations for pharmaceutical or medical purposes, namely, for restoring normal intracellular calcium regulation; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders; a full line of medicinal and pharmaceutical preparations; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders.
Class 42
Pharmaceutical research and development.

RyCarma Therapeutics, Inc.

Representative: Mishcon de Reya LLP